33,380 Shares of Danaher Corporation $DHR Purchased by Lineweaver Wealth Advisors LLC

Lineweaver Wealth Advisors LLC acquired a new position in shares of Danaher Corporation (NYSE:DHR) in the third quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 33,380 shares of the conglomerate’s stock, valued at approximately $7,395,000. Danaher makes up approximately 0.9% of Lineweaver Wealth Advisors LLC’s holdings, making the stock its 29th biggest position.

A number of other large investors have also recently made changes to their positions in the company. BlackRock Inc. acquired a new stake in Danaher in the second quarter valued at approximately $10,492,520,000. Jupiter Topco LLC purchased a new position in Danaher in the second quarter worth approximately $1,456,317,000. Generation Investment Management LLP acquired a new position in Danaher during the 2nd quarter worth approximately $1,287,949,000. Bank of America Corp DE acquired a new position in Danaher during the 2nd quarter worth approximately $993,846,000. Finally, Legal & General Group Plc acquired a new position in Danaher during the 2nd quarter worth approximately $801,056,000. 79.05% of the stock is currently owned by hedge funds and other institutional investors.

Danaher Stock Up 0.9%

DHR stock traded up $2.10 during trading on Tuesday, hitting $223.30. 6,007,508 shares of the company’s stock were exchanged, compared to its average volume of 4,462,041. The business has a 50-day moving average price of $212.41 and a two-hundred day moving average price of $195.13. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48. The stock has a market capitalization of $156.98 billion, a price-to-earnings ratio of 39.66, a PEG ratio of 2.74 and a beta of 0.76. Danaher Corporation has a 52-week low of $160.93 and a 52-week high of $242.80.

Danaher (NYSE:DHR) last announced its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The company had revenue of $6.26 billion for the quarter, compared to analyst estimates of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The firm’s revenue was up 5.5% on a year-over-year basis. During the same period in the prior year, the firm posted $0.77 earnings per share. As a group, equities research analysts expect that Danaher Corporation will post 8.53 EPS for the current year.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be given a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.7%. The ex-dividend date is Wednesday, September 30th. Danaher’s payout ratio is currently 28.42%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on DHR shares. TD Cowen increased their price objective on shares of Danaher from $236.00 to $255.00 and gave the company a “buy” rating in a research report on Tuesday. Wells Fargo & Company decreased their price objective on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Guggenheim boosted their target price on shares of Danaher from $200.00 to $250.00 and gave the stock a “buy” rating in a research note on Thursday, October 1st. UBS Group began coverage on Danaher in a report on Wednesday, September 9th. They issued a “buy” rating and a $250.00 target price on the stock. Finally, Wall Street Zen upgraded Danaher from a “hold” rating to a “buy” rating in a research note on Saturday. Two investment analysts have rated the stock with a Strong Buy rating, seventeen have issued a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher has an average rating of “Moderate Buy” and an average target price of $235.41.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops and manufactures products, services and solutions for the life sciences, diagnostics and biotechnology industries. Its offerings help researchers, healthcare professionals and biopharmaceutical manufacturers discover, develop, produce and analyze medicines and other biological products.

The company operates through businesses that provide laboratory instruments, consumables, software and services, including technologies for cell analysis, genomics, protein research, bioprocessing and clinical diagnostics.